Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

Francesco Dentali; Davide Imberti; Eleonora Tamburini Permunian; Ezio Croci; Walter Ageno

doi:10.1160/TH13-10-0851

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 112(03): 621-623
DOI: 10.1160/TH13-10-0851

Letters to the Editor

Schattauer GmbH

Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal

Francesco Dentali

¹Department of Clinical Medicine Insubria University, Varese, Italy

,

Davide Imberti

²Haemostasis and Thrombosis Center, Department of Internal Medicine, Piacenza Hospital, Piacenza, Italy

,

Eleonora Tamburini Permunian

¹Department of Clinical Medicine Insubria University, Varese, Italy

,

Ezio Croci

³Clinical Pathology, Piacenza Hospital, Piacenza, Italy

,

Walter Ageno

¹Department of Clinical Medicine Insubria University, Varese, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Ageno W, Gallus AS, Wittkowsky A. et al. American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) Suppl e44S-488S.
2 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
3 Ageno W, Garcia D, Aguilar MI. et al. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol 2009; 84: 584-588.
4 Libby EN, Garcia DA. A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med 2002; 162: 1893-1896.
5 Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006; 04: 1853-1863.
6 Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol 2008; 25: 784-789.
7 Dentali F, Marchesi C, Pierfranceschi MG. et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011; 106: 429-438.
8 Baggs JH, Patanwala AE, Williams EM. et al. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Ann Pharmacother 2012; 46: 51-56.
9 Holland L, Warkentin TE, Refaai M. et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supra-therapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
10 Imberti D, Magnacavallo A, Dentali F. et al. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. J Thromb Thrombolysis 2013; 36: 102-108.
11 Imberti D, Barillari G, Biasioli C. et al. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb 2008; 36: 259-265.
12 Menzin J, Hoesche J, Friedman M. et al. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost 2012; 10: 596-605.